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Obesity has been increasing in epidemic proportions in both adults and children over many decades, and recently the proportion of the population with more severe, or morbid, obesity has increased to a greater extent than has overweight and mild obesity. [1] [2] [3] Currently, nearly 70% of adults are classified as either overweight or obese as compared with fewer than 40% just forty years ago. 3 One can argue about the impact of overweightness and mild obesity on overall prognosis particularly without accounting for levels of cardiorespiratory fitness (fitness). Nevertheless, very recent high profile data have suggested obesity may account for nearly 20% of overall mortality. 4 There are numerous adverse effects of overweightness and obesity on general and cardiovascular (CV) health. 3 Clearly, obesity worsens most of the major CV risk factors, including plasma lipids, blood pressure, glucose, inflammation, and places a "heavy" burden on the heart, negatively impacting ventricular structure and systolic and diastolic ventricular function. 3, 5, 6 Not surprisingly, obesity is associated with the prevalence of most CV diseases, including hypertension, coronary heart disease (CHD), heart failure (HF), and atrial fibrillation (AF). 3, 5 Nevertheless, substantial data, mostly published during the last decade, have demonstrated an "obesity paradox", where obese patients generally have a better short-and longterm prognosis then do their leaner counterparts with the same CV diseases. 3, 5 This state of the art briefly reviews the pathophysiology/hemodynamics of obesity, discusses possible causes of the obesity epidemic, and reviews the changing landscape of obesity on survival in the general population and in those with CV diseases, including HTN, CHD, HF, and AF. Additionally, we discuss the impact of severe or morbid obesity on prognosis, especially in light of the obesity paradox noted at least in overweight and mildly obese patients with CV diseases. We also discuss the role of cardiorespiratory fitness (fitness) compared with fatness, M A N U S C R I P T
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CV Pathophysiology/Hemodynamics
Overweightness and obesity have many adverse effects on hemodynamics and CV structure and function ( Figure 1 , Table 1 ) 5 which have been reviewed in detail elsewhere. 3, 5 Obesity certainly increases total blood volume, stroke volume and cardiac output, so typically systemic vascular resistance in obesity is reduced for any given level of BP. Although most of the increases in cardiac output in obesity are due to high stroke volume (as heart rate is typically not increased), occasionally, heart rate may be slightly increased due to increased activation of the sympathetic nervous system. The Frank-Starling curve in obesity is often shifted to the left due to increases in filling pressure and volume, which increases CV work, also leading to left ventricular (LV) changes with dilatation and LV hypertrophy (LVH). Additionally, obesity can leads to enlargement of the left atrium, both from the increased circulating blood volume but also due to alterations in LV diastolic filling. 5, 7 From multiple mechanisms, obesity has adverse effects on both systolic and, especially, diastolic ventricular function.
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Etiologies of Obesity and Energy Balance
During recent years, the origins of the obesity epidemic have been in considerable dispute. 9, 10 Regardless of this debate, it is widely accepted that increments in body weight and overall adiposity, at the most fundamental level, are the result of chronic positive energy balance (that is, energy expenditure < energy intake). 11, 12 There has been a number of studies suggesting that energy or food intake is largely, if not completely, responsible for the obesity epidemic, essentially blaming much of the obesity epidemic in Westernized World on poor dietary choices. [13] [14] [15] One of the arguments to support this theory is that time spent in leisure-time
physical activity has remained essentially unchanged in recent decades, thus leading to the conclusion that obesity is solely due to excessive energy or caloric intake. 11 However, leisuretime physical activity represents a relatively small portion of total time per week, which is much more impacted by occupation-related activity and household management energy expenditure.
Recently, we have demonstrated very marked declines in occupation-related physical activity during the last five decades (Figure 2 ), 11 with similar declines in household management energy expenditure in women during this same time ( Figure 3) . 12, 16 In fact, the typical female now has an energy expenditure that is over 1800 calories/week less than that present five decades ago. 12 Considering the fact that generally 100 calories are burned for every mile traveled by foot, the typical female would have to walk or run over 18 miles/week to make up for this loss of household management energy expenditure. This suggests that reductions in occupation-related activity and energy expenditure, similar to household management energy expenditure in women, largely explain the marked increased prevalence in obesity noted during recent decades ( Figure 4 ).
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Importantly, because voluntary physical activity (e.g., housework, exercise) is the only major modifiable component of total daily energy expenditure, these significant reductions are independent of the relatively non-modifiable components of total daily energy expenditure such as resting metabolic rate, 17 thermic effect of food, 18 and non-exercise activity thermogenesis . 19, 20 M A N U S C R I P T A C C E P T E D or "morbid" obesity has been markedly increasing, now approaching 3 % prevalence in the US. [1] [2] [3] Clearly, efforts to prevent and reverse these severe degrees of obesity are needed, whereas the data to support intervention in overweight and mild obesity is less so.
Obesity Paradox
Despite the adverse impact of overweightness and obesity on most of the CV risk factors as well as increasing the prevalence of most CV diseases, numerous studies during the past decade demonstrate a clear obesity paradox, where overweight and obese with CV diseases have a better prognosis than do their leaner counterparts. 3 The mechanisms for this paradox are
performance to identify obesity in the general population and also in cohorts with CHD, [23] [24] [25] [26] which may explain some, although not all, of the paradoxes listed in this review. Therefore, we also briefly review the impact of other assessments of obesity, including waist circumference and body fat (BF).
Hypertension. Obese patients have a higher prevalence of hypertension compared with lean subjects, and obesity adversely impacts CHD risk factors and leads to increased prevalence of LVH, independent of arterial pressure. However, several studies demonstrate an obesity paradox in hypertensive subjects. The largest of such studies is from Uretsky et al 27 who investigated the effects of obesity on outcomes in 22,576 patients with treated hypertension and with known CHD. Despite an overall worse control of blood pressure during a 2-year follow-up, all-cause mortality was 30% lower in overweight and obese hypertensive patients compared with their lean counterparts. Other studies have either demonstrated the same finding or demonstrated a U-shaped relationship between BMI and all-cause, CV, and non-CV mortality, being that excess mortality was noted at both extremes of BMI. 3 Certainly, overweight and morbidly obese hypertensive patients seem to have a better prognosis than do their leaner counterparts.
CHD. Obesity plays a major role in adversely affecting CHD risk factors and increasing the prevalence of CHD, 3 although some studies indicate that CHD may not be increased in "metabolically healthy" obesity. 28-31 Nevertheless, as with hypertension, many studies using various measures of adiposity, including BMI, 32-41 % body fat (BF), [33] [34] [35] and some even with central obesity or waist circumference (WC) 34 have demonstrated an obesity paradox in CHD.
Romero-Corral and colleagues 32 performed a meta-analysis of 40 cohort studies in over 250,000
patients with CHD and reported that overweight and obese CHD patients have a lower risk of total and CV mortality compared with underweight and normal-weight CHD patients. However, Several recent studies have raised the possibility that the association with lower adiposity and worse outcomes in CHD may represent as much as a "lean paradox" as an obesity paradox. 33, 35, 38, 39 We have demonstrated this obesity paradox with low BF (defined as < 25% in men and < 35% in women) and low BMI, 33,40 and both low BF and low BMI are independent predictors of worse outcomes. However, in a study of 581 patients with CHD, we demonstrated that only those with low BMI (< 25 kg/m 2 ) and low BF had a high mortality compared with the other groups. 33 Most recently, we demonstrated that both low BF and low lean mass (or non-fat mass) is associated with the worst survival, patients with both high lean mass and BF had the best survival, whereas intermediate survival rates were noted in the other groups ( Figure 5) . 35 Other studies demonstrate that this may represent more of an "overweight paradox", where overweight CHD patients do particularly well compared with lean. 38, 39 Therefore, in CHD, it appears that there is a strong obesity paradox, particularly with BMI, but also with BF and central obesity, with the best prognosis noted in overweight CHD patients, as opposed to those with more severe obesity. of HF increasing across the entire spectrum of BMI. However, in a study of 550 subjects without diabetes, increased BMI was not associated with increased risks of HF, whereas metabolic syndrome increased the risk of HF by 2.5-fold. 43 In this study, in contrast to normal weight patients with metabolic syndrome, metabolically healthy obese subjects had a decreased HF risk in a 6-year follow-up. However, a recent study from Norway demonstrated that in contrast to CHD, metabolically healthy obese still had an increased risk of HF. 29 Alpert and colleagues 44 demonstrated a very strong relationship between morbid obesity and HF prevalence.
The obesity paradox in HF has recently been reviewed in detail. 5 In a meta-analysis of observational HF studies (N=28,209), Oreopoulous et al 45 demonstrated that compared with patients with normal BMI, overweight and obese HF patients had reductions in CV (-19% and -40%, respectively) and total mortality (-16% and -33% respectively) during an average 2.7 year follow-up. The obesity paradox in HF has been demonstrated with BMI, % BF, and with waist circumference or central obesity.
5,46-48
Atrial Fibrillation. As with obesity, the prevalence of atrial fibrillation has been increasing and is expected to increase by 2.5-fold during the next 30 years. 3 The increase in atrial fibrillation may be partly due to the obesity epidemic, with its adverse hemodynamic effects and the impact on LV and left atrial structure and function. 3, 7 In a meta-analysis of 16 studies of over 120,000 patients, Wanahita et al 49 demonstrate that obese had a 50% increased risk of developing AF. However, as in HTN, CHD, and HF, overweight and obese with atrial fibrillation have a considerably better prognosis than do those patients with normal levels of BMI.
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Impact of Morbid Obesity
The prevalence of morbid or Class III obesity (BMI ≥ 40 kg/m 2 ) has been dramatically increasing, and is now present in close to 3% of the US population. [59] [60] [61] [62] [63] [64] In most of these CV disorders, patients with high fitness have lower mortality than do patients without these disorders but with low levels of fitness. In a recent meta-analysis of 33 studies of over 100,000 participants, Kodama et al 58 demonstrated that for every one metabolic equivalent (MET) increase in fitness, all-cause mortality and CHD/CV events are reduced by 13% and 15%, respectively. In 66,371 subjects without prior CV disease from the Cooper Center Longitudinal Study, a single measure of fitness significantly improved classification of both 10-year and 25-year risks for CV mortality when added to traditional CV risk factors. 65 In a study of 3,148 healthy adults, changes over time in both adiposity (BMI and % BF) and fitness predicted the development of hypertension, metabolic syndrome, and hypercholesterolemia, but the impact of fitness appears somewhat better than did adiposity for future risk of these CV disorders.
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11 exercise stress tests separated by an average of 6.3 years in 14,345 men was associated with reductions in all-cause and CV mortality of 15% and 19%, respectively; BMI change was not associated with all-cause and CV mortality after adjusting for possible confounders and changes in fitness. 67 The constellation of these data suggest that although ideal prevention of ageassociated loss in fitness and increase in adiposity both may be useful, maintaining or improving fitness is more important than preventing increased adiposity with regards to long-term health outcomes.
Obesity Paradox and Fitness. Several studies have suggested that fitness markedly alters the relationship between adiposity and prognosis in both CHD and HF. 34, [68] [69] [70] In a recent study of nearly 10,000 patients with CHD, only those in the bottom 33 percentile for age-and
gender-levels of fitness demonstrated an obesity paradox, which was present by BMI, %BF, and even by waist circumference or central obesity ( Figure 6 ). 34 On the other hand, CHD patients without low fitness had a good prognosis regardless of their level of adiposity, so no obesity paradox was apparent, which has been described elsewhere. 71 We recently demonstrated the same finding in 2,066 patients with systolic HF; in fact, HF patients with peak oxygen consumption (peak VO 2 ) < 14cc/kg/min had a poor prognosis, and a strong obesity paradox was cc/kg/min) had a good overall prognosis regardless of BMI, and again no obesity paradox was apparent ( Figure 7 ). 69 A recent study by Uretsky et al 72 however, of more than 5,000 patients with normal nuclear perfusion stress tests, demonstrated that an obesity paradox was maintained regardless of the level of fitness. Nevertheless, those with relatively preserved fitness (≥ 6 M A N U S C R I P T
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estimated METs) had an extremely low mortality of less than 1% per year, although the normal BMI group had a higher mortality (1.4%/year) compared with the overweight and obese (0.9%/year and 0.6%/year, respectively). 72, 73 None of these studies, however, have adequately accessed the impact of fitness on prognosis of patients with severe obesity, particularly with Class II and III obesity (BMI 35-40 and > 40 kg/m 2 , respectively). It is noteworthy, that in this latter group of patients, assessing levels of fitness can be challenging.
Role of Purposeful Weight Reduction
The role of purposeful weight reduction, except in the morbidly obese patient, where obesity is particularly detrimental to health outcomes, continues to be controversial. 3, 5, 74, 75 Some long-term studies have suggested that weight loss may be associated with increased mortality, 3, 76 and coupled with the obesity paradox discussed above, it has been suggested that purposeful weight loss can be detrimental. However, clearly lifestyle interventions with diet and exercise training and at least mild weight reduction have markedly reduced the prevalence of metabolic syndrome and type II diabetes mellitus, [77] [78] [79] although a recent large study in diabetes did not demonstrate survival benefits from small amounts of weight loss in diabetic subjects. 80 In a CHD study of 530 patients which demonstrated an obesity paradox, overweight and obese who were successful with purposeful weight reduction had a trend of lower mortality. 40 In a study of 1,500
CHD patients, intentional weight loss produced a lower incidence of CHD events over 4-year follow-up. 81 A small study of 377 CHD patients showed the benefits of weight loss on major CV events even in patients with BMI < 25 kg/m 2 .
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In hypertension, purposeful weight loss has resulted in marked improvements in arterial pressure and LV geometry. 83 In HF, weight loss, especially with bariatric surgery, has improved LV geometry, systolic and diastolic function, and clinical symptoms.
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13 obese patients are being referred for bariatric surgery. Although 30-day mortality may be higher than ideal due to surgeon inexperience, 84 most studies in severely obese and diabetic patients are showing improvements in short-and long-term prognosis. 3, [85] [86] [87] [88] [89] Although better large scale weight loss intervention trials are needed, the constellation of data still supports purposeful weight reduction in patients with CV diseases, especially in the more severe obesity (probably BMI > 35 kg/m 2 and especially BMI > 40 kg/m 2 ). Considering the importance of fitness to improve prognosis in almost every patient group studied, including overweight and obese patients, as well as the clear evidence that improvements in fitness are associated with reductions in mortality in both CHD 33,90,91 and HF, 69, 92 incorporating exercise training and efforts to improve fitness into weight loss programs appears to be particularly beneficial.
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Conclusion
Although obesity adversely impacts CV risk factors and LV structure and function and is associated with increased risk of most CV diseases, an obesity paradox exists showing that overweight and obese with CV diseases have a better prognosis than do their leaner counterparts.
This obesity paradox seems largely apparent in patients with low fitness, whereas those with better fitness have a good prognosis and no clear obesity paradox is apparent. Although better long-term intervention studies are needed, purposeful weight reduction, and especially incorporating exercise training and improvements in fitness, seems to be beneficial. Figure 1 . Pathophysiology of Obesity Cardiomyopathy. This diagram shows the central hemodynamic, cardiac structural abnormalities and alterations in ventricular function that may occur in severely obese patients and predispose to heart failure. Left ventricular (LV) hypertrophy in severe obesity may be eccentric or concentric. In uncomplicated (normotensive) severe obesity, eccentric LV hypertrophy predominates. In severely obese patients with longstanding systemic hypertension, concentric LV hypertrophy is frequently observed and may occur more commonly than eccentric LV hypertrophy. Whether and to what extent metabolic disturbances such as lipotoxicity, insulin resistance, leptin resistance and alterations of the reninangiotensin-aldosterone system contribute to obesity cardiomyopathy in humans is uncertain. RV = right ventricular. Adapted with permission from Lavie CJ et al. 
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